From the article…
The Indiana board is committed to protecting citizens, Director Greg Pachmayr said, board investigators conduct unannounced inspections in compounding facilities.
The pharmacy board is doing the best it can, pharmacy law expert andPurdue University professor G. Thomas Wilder said, but that might not be enough.
Indiana’s board has a handful of investigators, Wilder said. After last year’s outbreak, other states’ legislatures expanded their regulatory agencies’ budgets and staff. The Indiana General Assembly hasn’t responded to last year’s outbreak with similar legislation.
Ninety-one people in Indiana developed illness or injury from the outbreak, and 11 died. What’s more is FDA observers found unsafe conditions at an Indianapolis facility in April.
The Indiana Board of Pharmacy is probably underbudget and understaffed, State Rep. Steve Davisson, R-Salem, said. Davisson is Vice Chairman of the Indiana General Assembly’s Public Health Committee.
He said the Legislature will likely wait and see what happens to the bill in Congress. Voting on that bill isn’t scheduled yet, so it’s far from law.